ANAB vs BIIB: Which Stock is Better?

Side-by-side comparison of Anaptysbio Inc and Biogen Inc in 2026

Comparison Updated:

ANAB

Anaptysbio Inc

$55.67

BIIB

Biogen Inc

$196.00

Key Metrics Comparison

MetricANABBIIBWinner
Market Cap$1.69B$29.08BBIIB
P/E RatioN/A21.16BIIB
EPS (TTM)$N/A$9.31BIIB
Revenue Growth-0.1%0.0%BIIB
Gross Margin44.6%78.7%BIIB

Analyze ANAB

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ANAB or BIIB a better investment?

Comparing ANAB and BIIB: Anaptysbio Inc has a market cap of $1.69B while Biogen Inc has $29.08B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ANAB and BIIB?

ANAB (Anaptysbio Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ANAB or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ANAB or BIIB?

BIIB has higher revenue growth at 0.0% vs -0.1% for ANAB.

Which company is more profitable: ANAB or BIIB?

Biogen Inc (BIIB) has higher gross margins at 78.7% compared to 44.6% for ANAB.

Which is the larger company: ANAB or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $29.08B compared to $1.69B for ANAB.

Should I buy ANAB or BIIB in 2026?

Both ANAB and BIIB have investment merit. ANAB trades at $55.67 while BIIB trades at $196.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ANAB and BIIB stock?

Key differences: Market Cap ($1.69B vs $29.08B), P/E Ratio (N/A vs 21.2x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (44.6% vs 78.7%).

Popular Stock Comparisons